DOW vs INTS
Dow Inc (DOW) versus Intensity Therapeutics, Inc. Common stock (INTS) — a side-by-side from cached financials, not a winner call.
Dow Inc (DOW) is a chemicals company listed on US.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Latest reported DOW revenue for 2024-12-31 was $42.96B. Net income was $1.20B. Revenue was down 3.7% from 2023-12-31 to 2024-12-31. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
INTS does not have a complete income-statement cache yet.
DOW currently screens at market cap $20.89B and trailing P/E 73.9. INTS currently screens at market cap $7.7M.
Not investment advice. Open the DOW and INTS stock pages for the full models.
Not investment advice.